QQ客服 官方微博 反馈留言

	Isorhynchophylline enhances Nrf2 and inhibits MAPK pathway in cardiac hypertrophy
	Zhang Y.; Cui Y.; Dai S.; Deng W.; Wang H.; Qin W.; Yang H.; Liu H.; 等 更多
刊名	Naunyn-Schmiedeberg's Archives of Pharmacology
	2019
关键词	Cardiac hypertrophy Fibrosis Isorhynchophylline Oxidative stress Remodeling
DOI	10.1007/s00210-019-01716-0
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4557119
专题	山东大学
作者单位	Department of Cardiology, The affiliated Hospital of Qingdao University, Qingdao, 266000, China, Key Laboratory of Cardiovascular Remodelin
推荐引用方式 GB/T 7714	Zhang Y.,Cui Y.,Dai S.,et al. Isorhynchophylline enhances Nrf2 and inhibits MAPK pathway in cardiac hypertrophy[J]. Naunyn-Schmiedeberg's Archives of Pharmacology,2019.
APA	Zhang Y..,Cui Y..,Dai S..,Deng W..,Wang H..,...&等 更多.(2019).Isorhynchophylline enhances Nrf2 and inhibits MAPK pathway in cardiac hypertrophy.Naunyn-Schmiedeberg's Archives of Pharmacology.
MLA	Zhang Y.,et al."Isorhynchophylline enhances Nrf2 and inhibits MAPK pathway in cardiac hypertrophy".Naunyn-Schmiedeberg's Archives of Pharmacology (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。